CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 379 enrolled
Drug / intervention
Advisor HD Grid Mapping Catheter, Sensor Enableddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03733392
NCT03733392N/ACompleted
CompareCT.gov

Advisor High Density (HD) Grid Mapping Catheter Observational Study

Abbott Medical Devices·observational·Posted Nov 7, 2018·Updated Apr 16, 2024

In Brief

An observational study evaluating Advisor HD Grid Mapping Catheter, Sensor Enabled for Persistent Atrial Fibrillation and Ventricular Tachycardia. Completed, enrolled 379 participants across 25 sites in 11 countries.

Detailed Summary

The aim of this study is to quantify and characterize the outcomes of radiofrequency (RF) ablation after, and the utility of electroanatomical mapping with the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ (hereafter called "HD Grid") and EnSite Precision™ Cardiac Mapping System (SV 2.2 or higher, hereafter called "EnSite Precision") with HD Wave Solution™ voltage mapping (hereafter called "HD Wave Solution") in subjects with persistent atrial fibrillation (PersAF) or ventricular tachycardia (VT) in real-world clinical settings.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPersistent Atrial Fibrillation, Ventricular Tachycardia
CountriesAustralia, Austria, Canada, Denmark, France, Germany, Italy, Netherlands, Portugal, South Africa, Spain
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 7, 2018
Enrollment StartJan 11, 2019
Primary CompletionMay 27, 2021
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 7.7 years ago

Interventions

Advisor HD Grid Mapping Catheter, Sensor Enableddevice

The Advisor™ HD Grid Mapping Catheter, Sensor Enabled™, is indicated for multiple electrode electrophysiological mapping of cardiac structures in the heart, i.e., recording or stimulation only. This catheter is intended to obtain electrograms in the atrial and ventricular regions of the heart.